Search results
Results from the WOW.Com Content Network
Unlike many effects of stroke, where the clinician is able to judge the particular area of the brain that a stroke has injured by certain signs or symptoms, the causation of apraxia is less clear. A common theory is that the part of the brain that contains information for previously learned skilled motor activities has been either lost or ...
ECT is generally a second-line treatment for people with catatonia who do not respond to other treatments, but is a first-line treatment for severe or life-threatening catatonia. [ 4 ] [ 49 ] [ 50 ] There is a plethora of evidence for its efficacy, notwithstanding a lack of randomised controlled trials, such that "the excellent efficacy of ECT ...
CT and MRI are most commonly used to observe the brain for cerebral atrophy. A CT scan takes cross sectional images of the brain using X-rays, while an MRI uses a magnetic field. With both measures, multiple images can be compared to see if there is a loss in brain volume over time. [20]
A cerebroprotectant (formerly known as a neuroprotectant) is a drug that is intended to protect the brain after the onset of acute ischemic stroke. [1] As stroke is the second largest cause of death worldwide and a leading cause of adult disability, over 150 drugs have been tested in clinical trials to provide cerebroprotection.
Put the phone down and grab a book. Whether you prefer a steamy romance novel, a fascinating piece of nonfiction, or a moody mystery, reading boasts tons of benefits for your brain.
Watershed stroke symptoms are due to the reduced blood flow to all parts of the body, specifically the brain, thus leading to brain damage. Initial symptoms, as promoted by the American Stroke Association, are FAST, representing F = Facial weakness (droop), A = Arm weakness (drift), S = Speech difficulty (slur), and T = Time to act (priority of intervention).
Doctor Sundeep Khosla is a professor of medicine and physiology at the Mayo Clinic. "Everybody shrinks as we age: women and men," Khosla said. One of the reasons for shrinking with age is ...
New cancer trial is a ‘lifeline’, says 62-year-old Paul Read who would’ve had less than a year to live due to aggressive brain tumour Man sees deadly brain tumour shrink by half thanks to a ...